Medical Condition

vascular diseases

Total Trials

10

Recruiting Now

10

Trial Phases

Phase 3, Phase 4, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for vascular diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — vascular diseases Clinical Trials

How many clinical trials are currently recruiting for vascular diseases?

ClinicalMetric currently tracks 10 actively recruiting clinical trials for vascular diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for vascular diseases?

vascular diseases research spans Phase 1 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a vascular diseases clinical trial?

Eligibility criteria for vascular diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 3

Phase 4

Top Sponsors

University of Oxford 1 trial

National Heart, Lung, and Blood Institute (NHLBI) 1 trial

Konkuk University Medical Center 1 trial

Pulnovo Medical (Wuxi) Co., Ltd. 1 trial

University of Colorado, Denver 1 trial

Recruiting Clinical Trials

NCT05683093

Recruiting

Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood

Thrombosis and Inflammation in Vessels Initiative (TIVI)

National Heart, Lung, and Bloo...

View Trial →

NCT05806346

Recruiting

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Konkuk University Medical Cent...

View Trial →

NCT05824923 Phase 3

Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Pulnovo Medical (Wuxi) Co., Lt...

View Trial →

NCT05005793 Phase 4

Recruiting

Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients

University of Colorado, Denver

View Trial →

NCT05522218

Recruiting

Eluvia DES for the Patients with Femoropopliteal Artery Lesions.

First Affiliated Hospital of Z...

NCT06510322 EARLY_Phase 1

Recruiting

Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support

Montefiore Medical Center

View Trial →

NCT05309707

Recruiting

ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"

Vascular Investigation Network...

View Trial →

NCT06819657

Recruiting

Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping

Beijing Tiantan Hospital

View Trial →

Related Conditions

cardiovascular diseases (6) hypertension (3) young adult (1) hypertension in pregnancy (1) cerebrovascular diseases (1) heart diseases (1) transfusion related complication (1) coagulation disorder blood (1) fibrinolysis hemorrhage (1) pulmonary hypertension (1) heart failure with reduced ejection fraction (1) heart failure (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology